A critical evaluation of the cost-effectiveness of radon protection methods in new homes in a radon affected area of England.

In the UK, building new homes in areas prone to radon gas is currently subject to regulations that require installation of radon-proof membranes. These membranes are not, however, the only way to protect residents of new homes against radon's potential to cause lung cancer. Alternative regulatory regimes can be constructed that would achieve the same end.

A cost-effectiveness analysis of radon protection methods in domestic properties: a comparative case study in Brixworth, Northamptonshire, UK.

Building regulations in the UK have since 1992 required that radon-proof membranes be installed in new domestic properties to protect residents against the adverse effects of radon. This study compares the cost-effectiveness of the current regulatory regime with an alternative that would entail new properties being tested for radon after construction, and being remediated if necessary. The alternative regime is found to be more cost-effective for a sample of properties in Brixworth, Northamptonshire, UK.

The cost-effectiveness of radon-proof membranes in new homes: a case study from Brixworth, Northamptonshire, UK.

Installing radon-proof membranes in new homes can reduce the exposure of those living in the properties to the radiation caused by a build up of radon gas. This paper considers whether doing so is cost-effective for a group of new houses constructed in the village of Brixworth, Northamptonshire, UK. The measure of cost-effectiveness used is cost per quality-adjusted life-year gained.

A new methodology for cost-effectiveness studies of domestic radon remediation programmes: quality-adjusted life-years gained within primary care trusts in central England.

Radon is a naturally occurring radioactive gas, high levels of which are associated with geological formations such as those found in Northamptonshire and North Oxfordshire in the UK. The UK's National Radiological Protection Board have designated both districts as radon Affected Areas. Radiation levels due to radon, therefore, exceed 200 Bq m(-3), the UK's domestic Action Level, in over one percent of domestic properties.

Evaluating the health benefits and cost-effectiveness of the radon remediation programme in domestic properties in Northamptonshire, UK.

Although previous analysis of health benefits and cost-effectiveness of radon remediation in a series of houses in Northamptonshire suggested that testing and remediation was justified, recent results indicate fewer predicted affected houses than previously assumed. Despite numerous awareness campaigns, limited numbers of householders have tested their homes, only a minority of affected householders have remediated, and those most at risk generally fail to remediate. Moreover, a recent survey shows a wide range of public perception of radon risk, not significantly influenced by public health campaigns.

A cost-effectiveness analysis of domestic radon remediation in four primary care trusts located in Northamptonshire, UK.

The paper considers how primary care trusts (PCTs), which are relatively new organisations in the UK health service, might respond to the health hazards associated with radon in domestic properties. To this end, the cost-effectiveness of radon remediation programmes in four primary care trusts is calculated and compared with those of other interventions that can avert and treat lung cancer. The results suggest remediation programmes in the primary care trusts are cost-effective on various criteria.

A critical comparison of the cost-effectiveness of domestic radon remediation programmes in three counties of England.

Radon remediation programmes in domestic dwellings were carried out in five areas, from three counties of England, and the total costs obtained. A single company, which abided by the Code of Practice of the Radon Council of Great Britain, carried out the remediation. The dose savings from the programmes were calculated and used to estimate the number of lung cancers averted.